Delivery Order SPE2DB24D1205-SPE2DB24FCRVT
- Not listed
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $9,590.46 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024 with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing...
- This federal contract award is for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,402.58 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 15, 2024 with a completion date of July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $2,384.96 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 5, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- The federal contract award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,144.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is set for April 22, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $5,341.33 firm fixed-price delivery order has a period of performance through December 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $3,975.72 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 18, 2024, with a completion date of January 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,896.32 firm fixed-price delivery order contract is for the provision of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of June 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,192.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 12, 2024. The contract has an ultimate completion date of July 15, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,264.51 firm fixed-price delivery order is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the provision of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceuticals to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $26,320.17 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and does not have a set-aside designation, indicating open competition....
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCRVTDelivery Order
This federal contract award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $9,996.17 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 6/6/24 |